Global Anti-PD-1 Antibody Market Growth 2025-2031

December 2025 | 127 pages | ID: G4E1A3B74FEAEN
LP Information

Abstracts

The global Anti-PD-1 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Anti-PD-1 Antibody is used to inhibit PD-1 and its downstream signaling pathways.

United States market for Anti-PD-1 Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Anti-PD-1 Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Anti-PD-1 Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Anti-PD-1 Antibody players cover Bio X Cell, Thermo Fisher, InvivoGen, BioVision Inc, Abcam, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Anti-PD-1 Antibody Industry Forecast” looks at past sales and reviews total world Anti-PD-1 Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-PD-1 Antibody sales for 2025 through 2031. With Anti-PD-1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-PD-1 Antibody industry.

This Insight Report provides a comprehensive analysis of the global Anti-PD-1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-PD-1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-PD-1 Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-PD-1 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-PD-1 Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-PD-1 Antibody market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Monoclonal
• Polyclonal

Segmentation by Application:

• IHC-P
• ICC/IF
• WB
• Flow Cytometry
• ELISA

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bio X Cell
• Thermo Fisher
• InvivoGen
• BioVision Inc
• Abcam
• Bristol-Myers Squibb (BMS)
• Merck
• Ono Pharmaceutical Co., Ltd
• Lilly
• Chugai Pharmaceutical Co., Ltd
• BeiGene
• Abbvie
• TG Therapeutics, Inc
• Novartis
• Arcus Biosciences
• Sino Biological Inc
• 3SBio Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-PD-1 Antibody market?

What factors are driving Anti-PD-1 Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-PD-1 Antibody market opportunities vary by end market size?

How does Anti-PD-1 Antibody break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-PD-1 Antibody Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Anti-PD-1 Antibody by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Anti-PD-1 Antibody by Country/Region, 2020, 2024 & 2031
2.2 Anti-PD-1 Antibody Segment by Type
  2.2.1 Monoclonal
  2.2.2 Polyclonal
2.3 Anti-PD-1 Antibody Sales by Type
  2.3.1 Global Anti-PD-1 Antibody Sales Market Share by Type (2020-2025)
  2.3.2 Global Anti-PD-1 Antibody Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Anti-PD-1 Antibody Sale Price by Type (2020-2025)
2.4 Anti-PD-1 Antibody Segment by Application
  2.4.1 IHC-P
  2.4.2 ICC/IF
  2.4.3 WB
  2.4.4 Flow Cytometry
  2.4.5 ELISA
2.5 Anti-PD-1 Antibody Sales by Application
  2.5.1 Global Anti-PD-1 Antibody Sale Market Share by Application (2020-2025)
  2.5.2 Global Anti-PD-1 Antibody Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Anti-PD-1 Antibody Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Anti-PD-1 Antibody Breakdown Data by Company
  3.1.1 Global Anti-PD-1 Antibody Annual Sales by Company (2020-2025)
  3.1.2 Global Anti-PD-1 Antibody Sales Market Share by Company (2020-2025)
3.2 Global Anti-PD-1 Antibody Annual Revenue by Company (2020-2025)
  3.2.1 Global Anti-PD-1 Antibody Revenue by Company (2020-2025)
  3.2.2 Global Anti-PD-1 Antibody Revenue Market Share by Company (2020-2025)
3.3 Global Anti-PD-1 Antibody Sale Price by Company
3.4 Key Manufacturers Anti-PD-1 Antibody Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Anti-PD-1 Antibody Product Location Distribution
  3.4.2 Players Anti-PD-1 Antibody Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ANTI-PD-1 ANTIBODY BY GEOGRAPHIC REGION

4.1 World Historic Anti-PD-1 Antibody Market Size by Geographic Region (2020-2025)
  4.1.1 Global Anti-PD-1 Antibody Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Anti-PD-1 Antibody Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-PD-1 Antibody Market Size by Country/Region (2020-2025)
  4.2.1 Global Anti-PD-1 Antibody Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Anti-PD-1 Antibody Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-PD-1 Antibody Sales Growth
4.4 APAC Anti-PD-1 Antibody Sales Growth
4.5 Europe Anti-PD-1 Antibody Sales Growth
4.6 Middle East & Africa Anti-PD-1 Antibody Sales Growth

5 AMERICAS

5.1 Americas Anti-PD-1 Antibody Sales by Country
  5.1.1 Americas Anti-PD-1 Antibody Sales by Country (2020-2025)
  5.1.2 Americas Anti-PD-1 Antibody Revenue by Country (2020-2025)
5.2 Americas Anti-PD-1 Antibody Sales by Type (2020-2025)
5.3 Americas Anti-PD-1 Antibody Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-PD-1 Antibody Sales by Region
  6.1.1 APAC Anti-PD-1 Antibody Sales by Region (2020-2025)
  6.1.2 APAC Anti-PD-1 Antibody Revenue by Region (2020-2025)
6.2 APAC Anti-PD-1 Antibody Sales by Type (2020-2025)
6.3 APAC Anti-PD-1 Antibody Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Anti-PD-1 Antibody by Country
  7.1.1 Europe Anti-PD-1 Antibody Sales by Country (2020-2025)
  7.1.2 Europe Anti-PD-1 Antibody Revenue by Country (2020-2025)
7.2 Europe Anti-PD-1 Antibody Sales by Type (2020-2025)
7.3 Europe Anti-PD-1 Antibody Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-PD-1 Antibody by Country
  8.1.1 Middle East & Africa Anti-PD-1 Antibody Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Anti-PD-1 Antibody Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-PD-1 Antibody Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-PD-1 Antibody Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-PD-1 Antibody
10.3 Manufacturing Process Analysis of Anti-PD-1 Antibody
10.4 Industry Chain Structure of Anti-PD-1 Antibody

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Anti-PD-1 Antibody Distributors
11.3 Anti-PD-1 Antibody Customer

12 WORLD FORECAST REVIEW FOR ANTI-PD-1 ANTIBODY BY GEOGRAPHIC REGION

12.1 Global Anti-PD-1 Antibody Market Size Forecast by Region
  12.1.1 Global Anti-PD-1 Antibody Forecast by Region (2026-2031)
  12.1.2 Global Anti-PD-1 Antibody Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-PD-1 Antibody Forecast by Type (2026-2031)
12.7 Global Anti-PD-1 Antibody Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Bio X Cell
  13.1.1 Bio X Cell Company Information
  13.1.2 Bio X Cell Anti-PD-1 Antibody Product Portfolios and Specifications
  13.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Bio X Cell Main Business Overview
  13.1.5 Bio X Cell Latest Developments
13.2 Thermo Fisher
  13.2.1 Thermo Fisher Company Information
  13.2.2 Thermo Fisher Anti-PD-1 Antibody Product Portfolios and Specifications
  13.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Thermo Fisher Main Business Overview
  13.2.5 Thermo Fisher Latest Developments
13.3 InvivoGen
  13.3.1 InvivoGen Company Information
  13.3.2 InvivoGen Anti-PD-1 Antibody Product Portfolios and Specifications
  13.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 InvivoGen Main Business Overview
  13.3.5 InvivoGen Latest Developments
13.4 BioVision Inc
  13.4.1 BioVision Inc Company Information
  13.4.2 BioVision Inc Anti-PD-1 Antibody Product Portfolios and Specifications
  13.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 BioVision Inc Main Business Overview
  13.4.5 BioVision Inc Latest Developments
13.5 Abcam
  13.5.1 Abcam Company Information
  13.5.2 Abcam Anti-PD-1 Antibody Product Portfolios and Specifications
  13.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Abcam Main Business Overview
  13.5.5 Abcam Latest Developments
13.6 Bristol-Myers Squibb (BMS)
  13.6.1 Bristol-Myers Squibb (BMS) Company Information
  13.6.2 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolios and Specifications
  13.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Bristol-Myers Squibb (BMS) Main Business Overview
  13.6.5 Bristol-Myers Squibb (BMS) Latest Developments
13.7 Merck
  13.7.1 Merck Company Information
  13.7.2 Merck Anti-PD-1 Antibody Product Portfolios and Specifications
  13.7.3 Merck Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Merck Main Business Overview
  13.7.5 Merck Latest Developments
13.8 Ono Pharmaceutical Co., Ltd
  13.8.1 Ono Pharmaceutical Co., Ltd Company Information
  13.8.2 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolios and Specifications
  13.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Ono Pharmaceutical Co., Ltd Main Business Overview
  13.8.5 Ono Pharmaceutical Co., Ltd Latest Developments
13.9 Lilly
  13.9.1 Lilly Company Information
  13.9.2 Lilly Anti-PD-1 Antibody Product Portfolios and Specifications
  13.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Lilly Main Business Overview
  13.9.5 Lilly Latest Developments
13.10 Chugai Pharmaceutical Co., Ltd
  13.10.1 Chugai Pharmaceutical Co., Ltd Company Information
  13.10.2 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolios and Specifications
  13.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Chugai Pharmaceutical Co., Ltd Main Business Overview
  13.10.5 Chugai Pharmaceutical Co., Ltd Latest Developments
13.11 BeiGene
  13.11.1 BeiGene Company Information
  13.11.2 BeiGene Anti-PD-1 Antibody Product Portfolios and Specifications
  13.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 BeiGene Main Business Overview
  13.11.5 BeiGene Latest Developments
13.12 Abbvie
  13.12.1 Abbvie Company Information
  13.12.2 Abbvie Anti-PD-1 Antibody Product Portfolios and Specifications
  13.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Abbvie Main Business Overview
  13.12.5 Abbvie Latest Developments
13.13 TG Therapeutics, Inc
  13.13.1 TG Therapeutics, Inc Company Information
  13.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolios and Specifications
  13.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 TG Therapeutics, Inc Main Business Overview
  13.13.5 TG Therapeutics, Inc Latest Developments
13.14 Novartis
  13.14.1 Novartis Company Information
  13.14.2 Novartis Anti-PD-1 Antibody Product Portfolios and Specifications
  13.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Novartis Main Business Overview
  13.14.5 Novartis Latest Developments
13.15 Arcus Biosciences
  13.15.1 Arcus Biosciences Company Information
  13.15.2 Arcus Biosciences Anti-PD-1 Antibody Product Portfolios and Specifications
  13.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.15.4 Arcus Biosciences Main Business Overview
  13.15.5 Arcus Biosciences Latest Developments
13.16 Sino Biological Inc
  13.16.1 Sino Biological Inc Company Information
  13.16.2 Sino Biological Inc Anti-PD-1 Antibody Product Portfolios and Specifications
  13.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.16.4 Sino Biological Inc Main Business Overview
  13.16.5 Sino Biological Inc Latest Developments
13.17 3SBio Inc
  13.17.1 3SBio Inc Company Information
  13.17.2 3SBio Inc Anti-PD-1 Antibody Product Portfolios and Specifications
  13.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
  13.17.4 3SBio Inc Main Business Overview
  13.17.5 3SBio Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anti-PD-1 Antibody Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-PD-1 Antibody Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global Anti-PD-1 Antibody Sales by Type (2020-2025) & (Kg)
Table 6. Global Anti-PD-1 Antibody Sales Market Share by Type (2020-2025)
Table 7. Global Anti-PD-1 Antibody Revenue by Type (2020-2025) & ($ million)
Table 8. Global Anti-PD-1 Antibody Revenue Market Share by Type (2020-2025)
Table 9. Global Anti-PD-1 Antibody Sale Price by Type (2020-2025) & (USD/g)
Table 10. Global Anti-PD-1 Antibody Sale by Application (2020-2025) & (Kg)
Table 11. Global Anti-PD-1 Antibody Sale Market Share by Application (2020-2025)
Table 12. Global Anti-PD-1 Antibody Revenue by Application (2020-2025) & ($ million)
Table 13. Global Anti-PD-1 Antibody Revenue Market Share by Application (2020-2025)
Table 14. Global Anti-PD-1 Antibody Sale Price by Application (2020-2025) & (USD/g)
Table 15. Global Anti-PD-1 Antibody Sales by Company (2020-2025) & (Kg)
Table 16. Global Anti-PD-1 Antibody Sales Market Share by Company (2020-2025)
Table 17. Global Anti-PD-1 Antibody Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Anti-PD-1 Antibody Revenue Market Share by Company (2020-2025)
Table 19. Global Anti-PD-1 Antibody Sale Price by Company (2020-2025) & (USD/g)
Table 20. Key Manufacturers Anti-PD-1 Antibody Producing Area Distribution and Sales Area
Table 21. Players Anti-PD-1 Antibody Products Offered
Table 22. Anti-PD-1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Anti-PD-1 Antibody Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Anti-PD-1 Antibody Sales Market Share Geographic Region (2020-2025)
Table 27. Global Anti-PD-1 Antibody Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Anti-PD-1 Antibody Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Anti-PD-1 Antibody Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Anti-PD-1 Antibody Sales Market Share by Country/Region (2020-2025)
Table 31. Global Anti-PD-1 Antibody Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Anti-PD-1 Antibody Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Anti-PD-1 Antibody Sales by Country (2020-2025) & (Kg)
Table 34. Americas Anti-PD-1 Antibody Sales Market Share by Country (2020-2025)
Table 35. Americas Anti-PD-1 Antibody Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Anti-PD-1 Antibody Sales by Type (2020-2025) & (Kg)
Table 37. Americas Anti-PD-1 Antibody Sales by Application (2020-2025) & (Kg)
Table 38. APAC Anti-PD-1 Antibody Sales by Region (2020-2025) & (Kg)
Table 39. APAC Anti-PD-1 Antibody Sales Market Share by Region (2020-2025)
Table 40. APAC Anti-PD-1 Antibody Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Anti-PD-1 Antibody Sales by Type (2020-2025) & (Kg)
Table 42. APAC Anti-PD-1 Antibody Sales by Application (2020-2025) & (Kg)
Table 43. Europe Anti-PD-1 Antibody Sales by Country (2020-2025) & (Kg)
Table 44. Europe Anti-PD-1 Antibody Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Anti-PD-1 Antibody Sales by Type (2020-2025) & (Kg)
Table 46. Europe Anti-PD-1 Antibody Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Anti-PD-1 Antibody Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Anti-PD-1 Antibody Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Anti-PD-1 Antibody Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Anti-PD-1 Antibody Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Anti-PD-1 Antibody
Table 52. Key Market Challenges & Risks of Anti-PD-1 Antibody
Table 53. Key Industry Trends of Anti-PD-1 Antibody
Table 54. Anti-PD-1 Antibody Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Anti-PD-1 Antibody Distributors List
Table 57. Anti-PD-1 Antibody Customer List
Table 58. Global Anti-PD-1 Antibody Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Anti-PD-1 Antibody Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Anti-PD-1 Antibody Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Anti-PD-1 Antibody Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Anti-PD-1 Antibody Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Anti-PD-1 Antibody Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Anti-PD-1 Antibody Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Anti-PD-1 Antibody Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Anti-PD-1 Antibody Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Anti-PD-1 Antibody Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Anti-PD-1 Antibody Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Anti-PD-1 Antibody Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Anti-PD-1 Antibody Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Anti-PD-1 Antibody Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bio X Cell Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 73. Bio X Cell Anti-PD-1 Antibody Product Portfolios and Specifications
Table 74. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 75. Bio X Cell Main Business
Table 76. Bio X Cell Latest Developments
Table 77. Thermo Fisher Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 78. Thermo Fisher Anti-PD-1 Antibody Product Portfolios and Specifications
Table 79. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 80. Thermo Fisher Main Business
Table 81. Thermo Fisher Latest Developments
Table 82. InvivoGen Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 83. InvivoGen Anti-PD-1 Antibody Product Portfolios and Specifications
Table 84. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 85. InvivoGen Main Business
Table 86. InvivoGen Latest Developments
Table 87. BioVision Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 88. BioVision Inc Anti-PD-1 Antibody Product Portfolios and Specifications
Table 89. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 90. BioVision Inc Main Business
Table 91. BioVision Inc Latest Developments
Table 92. Abcam Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Abcam Anti-PD-1 Antibody Product Portfolios and Specifications
Table 94. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 95. Abcam Main Business
Table 96. Abcam Latest Developments
Table 97. Bristol-Myers Squibb (BMS) Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolios and Specifications
Table 99. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 100. Bristol-Myers Squibb (BMS) Main Business
Table 101. Bristol-Myers Squibb (BMS) Latest Developments
Table 102. Merck Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Anti-PD-1 Antibody Product Portfolios and Specifications
Table 104. Merck Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Ono Pharmaceutical Co., Ltd Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolios and Specifications
Table 109. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 110. Ono Pharmaceutical Co., Ltd Main Business
Table 111. Ono Pharmaceutical Co., Ltd Latest Developments
Table 112. Lilly Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. Lilly Anti-PD-1 Antibody Product Portfolios and Specifications
Table 114. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 115. Lilly Main Business
Table 116. Lilly Latest Developments
Table 117. Chugai Pharmaceutical Co., Ltd Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolios and Specifications
Table 119. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 120. Chugai Pharmaceutical Co., Ltd Main Business
Table 121. Chugai Pharmaceutical Co., Ltd Latest Developments
Table 122. BeiGene Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. BeiGene Anti-PD-1 Antibody Product Portfolios and Specifications
Table 124. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 125. BeiGene Main Business
Table 126. BeiGene Latest Developments
Table 127. Abbvie Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Abbvie Anti-PD-1 Antibody Product Portfolios and Specifications
Table 129. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 130. Abbvie Main Business
Table 131. Abbvie Latest Developments
Table 132. TG Therapeutics, Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolios and Specifications
Table 134. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 135. TG Therapeutics, Inc Main Business
Table 136. TG Therapeutics, Inc Latest Developments
Table 137. Novartis Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. Novartis Anti-PD-1 Antibody Product Portfolios and Specifications
Table 139. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 140. Novartis Main Business
Table 141. Novartis Latest Developments
Table 142. Arcus Biosciences Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. Arcus Biosciences Anti-PD-1 Antibody Product Portfolios and Specifications
Table 144. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 145. Arcus Biosciences Main Business
Table 146. Arcus Biosciences Latest Developments
Table 147. Sino Biological Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Sino Biological Inc Anti-PD-1 Antibody Product Portfolios and Specifications
Table 149. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 150. Sino Biological Inc Main Business
Table 151. Sino Biological Inc Latest Developments
Table 152. 3SBio Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. 3SBio Inc Anti-PD-1 Antibody Product Portfolios and Specifications
Table 154. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 155. 3SBio Inc Main Business
Table 156. 3SBio Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Anti-PD-1 Antibody
Figure 2. Anti-PD-1 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-PD-1 Antibody Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Anti-PD-1 Antibody Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-PD-1 Antibody Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-PD-1 Antibody Sales Market Share by Country/Region (2024)
Figure 10. Anti-PD-1 Antibody Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal
Figure 12. Product Picture of Polyclonal
Figure 13. Global Anti-PD-1 Antibody Sales Market Share by Type in 2025
Figure 14. Global Anti-PD-1 Antibody Revenue Market Share by Type (2020-2025)
Figure 15. Anti-PD-1 Antibody Consumed in IHC-P
Figure 16. Global Anti-PD-1 Antibody Market: IHC-P (2020-2025) & (Kg)
Figure 17. Anti-PD-1 Antibody Consumed in ICC/IF
Figure 18. Global Anti-PD-1 Antibody Market: ICC/IF (2020-2025) & (Kg)
Figure 19. Anti-PD-1 Antibody Consumed in WB
Figure 20. Global Anti-PD-1 Antibody Market: WB (2020-2025) & (Kg)
Figure 21. Anti-PD-1 Antibody Consumed in Flow Cytometry
Figure 22. Global Anti-PD-1 Antibody Market: Flow Cytometry (2020-2025) & (Kg)
Figure 23. Anti-PD-1 Antibody Consumed in ELISA
Figure 24. Global Anti-PD-1 Antibody Market: ELISA (2020-2025) & (Kg)
Figure 25. Global Anti-PD-1 Antibody Sale Market Share by Application (2024)
Figure 26. Global Anti-PD-1 Antibody Revenue Market Share by Application in 2025
Figure 27. Anti-PD-1 Antibody Sales by Company in 2025 (Kg)
Figure 28. Global Anti-PD-1 Antibody Sales Market Share by Company in 2025
Figure 29. Anti-PD-1 Antibody Revenue by Company in 2025 ($ millions)
Figure 30. Global Anti-PD-1 Antibody Revenue Market Share by Company in 2025
Figure 31. Global Anti-PD-1 Antibody Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Anti-PD-1 Antibody Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Anti-PD-1 Antibody Sales 2020-2025 (Kg)
Figure 34. Americas Anti-PD-1 Antibody Revenue 2020-2025 ($ millions)
Figure 35. APAC Anti-PD-1 Antibody Sales 2020-2025 (Kg)
Figure 36. APAC Anti-PD-1 Antibody Revenue 2020-2025 ($ millions)
Figure 37. Europe Anti-PD-1 Antibody Sales 2020-2025 (Kg)
Figure 38. Europe Anti-PD-1 Antibody Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Anti-PD-1 Antibody Sales 2020-2025 (Kg)
Figure 40. Middle East & Africa Anti-PD-1 Antibody Revenue 2020-2025 ($ millions)
Figure 41. Americas Anti-PD-1 Antibody Sales Market Share by Country in 2025
Figure 42. Americas Anti-PD-1 Antibody Revenue Market Share by Country (2020-2025)
Figure 43. Americas Anti-PD-1 Antibody Sales Market Share by Type (2020-2025)
Figure 44. Americas Anti-PD-1 Antibody Sales Market Share by Application (2020-2025)
Figure 45. United States Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Anti-PD-1 Antibody Sales Market Share by Region in 2025
Figure 50. APAC Anti-PD-1 Antibody Revenue Market Share by Region (2020-2025)
Figure 51. APAC Anti-PD-1 Antibody Sales Market Share by Type (2020-2025)
Figure 52. APAC Anti-PD-1 Antibody Sales Market Share by Application (2020-2025)
Figure 53. China Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 57. India Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Anti-PD-1 Antibody Sales Market Share by Country in 2025
Figure 61. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2020-2025)
Figure 62. Europe Anti-PD-1 Antibody Sales Market Share by Type (2020-2025)
Figure 63. Europe Anti-PD-1 Antibody Sales Market Share by Application (2020-2025)
Figure 64. Germany Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 65. France Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Application (2020-2025)
Figure 72. Egypt Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Anti-PD-1 Antibody Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Anti-PD-1 Antibody in 2025
Figure 78. Manufacturing Process Analysis of Anti-PD-1 Antibody
Figure 79. Industry Chain Structure of Anti-PD-1 Antibody
Figure 80. Channels of Distribution
Figure 81. Global Anti-PD-1 Antibody Sales Market Forecast by Region (2026-2031)
Figure 82. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Anti-PD-1 Antibody Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Anti-PD-1 Antibody Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Application (2026-2031)